// App-Quantinova.ai

PB2130 : Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Patients with Cancer-Associated Thrombosis. A Pooled Analysis of two Prospective Cohort Studies

Researchers

Presenter

  • C. Chapelle

Principal Investigators

  • P. Girard

  • B. Planquette

  • S. Acassat

  • N. Falvo

  • A. Lamblin

  • S. Laporte

  • G. Meyer

Medical Centers

  • CHU Saint-Etienne, Saint Etienne, France

  • SAINBIOSE, INSERM U 1059, Université Lyon, Saint‐Etienne, France

  • Institut Mutualiste Montsouris, Paris, France

  • F-CRIN INNOVTE Network, Saint Etienne, France

  • Hopital European Georges Pompidou, Paris, France

  • CHU de Dijon, Dijon, France

  • Leo-Pharma, Voisins le Bretonneux, France

  • Hopital European Georges Pompidou, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Tinzaparin

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • NCT02898051

  • NCT03099031

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved